Bonum Therapeutics Announces a $93M Series A Financing to Advance a Novel and Validated Class of Conditionally Active Therapies “We believe that this technology has broad potential and we are excited to apply it in new areas…” Nov 15, 2022 Press Release
Good Therapeutics Announces Acquisition of Conditionally Active PD-1-Regulated IL-2 Program by Roche “Given Roche’s expertise in this field and broad capabilities in oncology, we believe they are a perfect choice for taking this important program forward…” Sep 7, 2022 Press Release
